Skip to main content
. 2021 Oct 10;2:31. doi: 10.1186/s43556-021-00053-0

Fig. 5.

Fig. 5

Clonogenic survival upon siCldn treatment. Treatment with siCldn3 and siCldn4 was performed on human prostate cancer (a) LNCaP and (b) PC3 cells. c Crystal violet staining was performed to visualize colony formation. Data are shown as mean ± SD of 3 to 4 independent experiments where **** represents p < 0.0001